Trial Profile
Atorvastatin Toronto Retinal Vein Occlusion study (ATORVO)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Veno-occlusive disorders
- Focus Therapeutic Use
- Acronyms ATORVO
- 28 Aug 2007 New trial record.